Last week, we discussed stretch marks and how the skin responds to physical stress and change. This week, we're shifting focus to something far more urgent: skin cancer detection in the primary care setting and the five clinical mistakes that may be putting your patients at risk.

This issue is sponsored by DocUpdate, a free HIPAA-compliant digital assistant built by physicians for physicians. Their tools, including an intelligent prescribing assistant, AI medical translator for 23+ languages, and pharmaceutical concierge, are designed to give clinicians time back. More at https://docupdate.onelink.me/j4xR/DermPCP 

Skin cancer is the most common cancer in the United States, with over 5 million cases treated annually. Yet despite this prevalence, delays in detection remain common, not because providers lack awareness, but because screening protocols, risk stratification, and patient counseling often fall short in the chaos of a 15-minute visit. The stakes are high: melanoma caught early has a 99% five-year survival rate; caught late, that drops to around 32%.

Here are five clinical mistakes that compromise skin cancer detection in primary care and how to reset your approach.

The Mistake:
Scanning a patient's skin opportunistically during a visit without a structured head-to-toe approach leads to missed lesions, particularly in low-visibility areas like the scalp, back, and intergluteal cleft.

Why It Happens:
Time constraints push providers toward "spot-checking" only exposed or complaint-driven areas. Without a standardized protocol, high-risk zones are routinely overlooked.

The Evidence:
Scalp melanomas account for approximately 6% of all melanomas but 10% of melanoma deaths. Melanomas in areas patients cannot self-examine (scalp, back, posterior surfaces) are consistently diagnosed at more advanced stages. Research shows that many providers do not routinely examine the areas where melanoma commonly arises, and areas like the scalp, genitalia, and interdigital spaces are frequently skipped even during "complete" skin exams.

Patient Counseling Script:
"I'm going to do a full skin check today, which means looking at areas you might not check yourself, like your scalp, back, and between your toes. Skin cancers can show up anywhere, even in spots that don't see the sun."

The Mistake:
Focusing exclusively on patients who report significant sun exposure or sunburns while underreporting risk in those with darker skin types, indoor occupations, or limited recreational UV exposure.

Why It Happens:
The traditional narrative around skin cancer emphasizes UV exposure, leading to underscreening of populations perceived as "low-risk." Additionally, myths persist that darker skin is immune to skin cancer.

The Evidence:
Melanoma in patients with darker skin types is diagnosed at late stages 52% of the time in non-Hispanic Black patients and 26% of the time in Hispanic patients, compared to 16% in non-Hispanic white patients. Acral lentiginous melanoma, the most common melanoma subtype in Black, Asian, and Hispanic populations, occurs in non-sun-exposed areas like palms, soles, and nail beds.

Patient Counseling Script:
"Skin cancer isn't just about sun exposure. Some types appear in areas that never see the sun, like under your nails or on the soles of your feet. That's why I check everyone, regardless of skin tone or lifestyle."

The Mistake:
Using the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving) as the sole screening tool and dismissing lesions that don't meet all five parameters, particularly amelanotic melanomas or nodular subtypes.

Why It Happens:
The ABCDE mnemonic is taught as the gold standard but was designed primarily for superficial spreading melanoma. It underperforms for amelanotic (non-pigmented) melanomas, nodular melanomas, and rapidly growing lesions.

The Evidence:
Amelanotic melanomas represent 2 to 8% of all melanomas but are diagnosed at more advanced stages due to lack of pigmentation. Nodular melanomas, which account for 10 to 15% of cases, often lack asymmetry or irregular borders and instead present as rapidly growing, dome-shaped lesions.

Patient Counseling Script:
"Not all skin cancers look like textbook examples. Some are pink or flesh-colored, and some grow fast without changing color. If something new appears or changes quickly, we need to take a closer look, even if it doesn't look 'suspicious' at first glance."

The Mistake:
Choosing to "watch" a lesion without documentation, relying on memory or vague patient recall to determine if a lesion has changed at the next visit.

Why It Happens:
Providers lack standardized workflows for lesion photography, or they assume follow-up will naturally occur. Patients often forget what lesions looked like months prior.

The Evidence:
Serial photography improves melanoma detection rates by 23% compared to visual inspection alone. The "ugly duckling" sign, a lesion that looks different from a patient's other moles, is more reliably identified when images are available for comparison.

Patient Counseling Script:
"I'm going to take a photo of this spot so we can compare it at your next visit. If it changes in size, shape, or color, that's a red flag. You can also take photos at home using the same lighting and angle each time."

The Mistake:
Opting for observation over biopsy based on gestalt alone, without using dermoscopy or seeking teledermatology consultation for equivocal lesions.

Why It Happens:
Concern about overtreatment, patient anxiety, or unnecessary procedures drives conservative management. Dermoscopy is underutilized in primary care due to lack of training.

The Evidence:
Dermoscopy increases diagnostic accuracy for melanoma by 30% compared to naked-eye examination. AI-assisted dermoscopy combined with teledermatology has been shown to reduce unnecessary biopsies while maintaining high sensitivity for melanoma detection.

Patient Counseling Script:
"When I'm not 100% sure about a spot, I'd rather biopsy it than wait and wonder. A biopsy is quick, low-risk, and gives us a definitive answer. If I'm on the fence, I may also send a photo to a dermatologist for a second opinion before we decide."

Interested in reaching our 8,000+ subscribers?

Click here to learn more!

https://go.dermforprimarycare.com/newsletter-sponsor-lp 

Skin cancer detection is a primary care responsibility. Dermatology wait times average 32 to 50 days in many U.S. markets, and many patients never make it to that appointment. Primary care providers are often the first, and sometimes only, clinician to examine a patient's skin. The tools to improve detection are accessible: total body skin exams, dermoscopy, photography apps, and teledermatology platforms are all scalable, low-cost interventions.

The bigger shift is cultural: moving from opportunistic screening to systematic, equity-focused skin cancer detection that includes all skin types, all anatomic sites, and all patients, not just those who "look like they're at risk."

✅ Perform annual TBSE for patients with personal/family history of skin cancer, >50 moles, or history of immunosuppression
✅ Use the "ugly duckling" rule: Flag any lesion that looks different from the patient's other moles
✅ Photograph concerning lesions with a ruler or coin for scale; store in EHR or HIPAA-compliant app
✅ Incorporate dermoscopy or refer to teledermatology for equivocal lesions before defaulting to "watch and wait"
✅ Educate patients on self-exams: Provide handouts on the ABCDEs and warning signs like non-healing sores, rapidly growing nodules, or new spots in unusual locations
✅ Biopsy liberally: When in doubt, biopsy, especially for lesions that are new, changing, symptomatic (bleeding, itching), or located on high-risk sites (scalp, ears, nose, acral areas)

We have created this FREE Guide for you:

Take one of our modules

Here are our featured courses for today!

Skin cancer screening in primary care doesn't require a dermatology fellowship. It requires a systematic approach, equity-minded risk assessment, and a willingness to biopsy when in doubt. Every total body skin exam is an opportunity to catch melanoma early, close survival gaps in underserved populations, and potentially save a life. In a system where dermatology access is limited and delayed, primary care providers are the safety net. Make the exam count.

See you next Thursday, DERM Community.

Until then, stay curious and keep translating science into realistic hope.

Have a topic you'd like us to cover? Reply to this email.

DERM Community | Derm for Primary Care Team